NCT04711655 - Antireflux Ablation of the Cardia Mucosa vs Placebo for the Treatment of Gastroesophageal Reflux Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

December 31, 2023

Study Completion Date

February 7, 2025

Conditions

Gastroesophageal Reflux Disease

Interventions

PROCEDURE

ARMA (antireflux ablation of the cardiac mucosa)

is an endoscopy in which argon gas ablation of the cardiac mucosa

PROCEDURE

upper digestive endoscopy

Quality diagnostic upper gastrointestinal endoscopy will be performed without intervention in patients assigned to this treatment arm.

Trial Locations (9)

Hospital de San Agustín, Avilés

Hospital Germans Trias I Pujol, Badalona

Hospital Del Mar, Barcelona

Hospital de Cabueñes, Gijón

Hospital 12 de Octubre, Madrid

Hospital La Paz, Madrid

Complejo Hospitalario de Navarra, Pamplona

Hospital La Fe, Valencia

Hospital Rio Hortega, Valladolid

All Listed Sponsors

collaborator

Spanish Society of Digestive Endoscopy

OTHER

lead

Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal

OTHER